Lotte Non-Life Insurance Reports Q1 Net Loss of 19.8B KRW and Receives Management Improvement Order… Solvency Ratio Slightly Improves
Lotte Non-Life Insurance recorded a net loss of 19.8B KRW in Q1 2026, turning from a net profit of 11.3B KRW in the same period last year. The main cause is a massive investment loss of 55.7B KRW, driven by expanded valuation losses on foreign exchange and derivatives.
The company received a management improvement order from the Financial Services Commission on March 4, 2026. This followed the rejection of its previously submitted plan in response to a management improvement recommendation in November 2025. The order automatically suspends interest payments on hybrid securities and may impose additional financial burdens.
The K-ICS solvency ratio edged up to 164.42% (under the exception model) from 159.48% at year-end, but under the principle model it stands at 138.09%, still below the regulatory threshold of 150%. The insurance payment capability rating was downgraded to A- (negative review) in March 2026, reflecting ongoing financial health concerns.
No dividends are paid due to a no-distribution policy, and there are no share buyback or cancellation plans. Although the major shareholder (Vytura Ltd.) holds a stable 77.04% stake and insurance operations are profitable, investment losses and regulatory risks are weighing on enterprise value. The short-term stock outlook hinges on the approval of the management improvement plan and movements in interest rates and exchange rates.
[AI Comprehensive Analysis]Lotte Non-Life Insurance faces a significant adverse event with the management improvement order from regulators, supported by a Q1 net loss and a credit rating downgrade. While the solvency ratio marginally improved, it remains among the lowest in the industry, making capital augmentation urgent. If the improvement plan is not approved, the risk of being designated as a troubled financial institution warrants a cautious approach.
KOSPI Filing Information
Filing: [Correction of Description] Quarterly Report (2026.03)